Drugstore operator CVS is making a $69 billion supply for insurer Aetna because it tries to place itself as a one-cease store for Americans’ health care wants with prescribed drugs, clinics and insurance policy to cowl these items and providers.
The corporations introduced Sunday that CVS Health Corp. can pay about $207 in money and inventory for every share of Aetna Inc., a 29 per cent premium over Aetna’s inventory worth earlier than the first report about a potential deal in October.
The mammoth acquisition pairs a firm that runs greater than 9,700 drugstores and 1,100 walk-in clinics with an insurer overlaying round 22 million individuals.
CVS Health Corp. can also be considered one of the nation’s largest pharmacy profit managers, processing greater than a billion prescriptions a yr for insurance coverage corporations, together with Aetna.
Scroll down for video
The merger between CVS and Aetna comes amid rising medical prices for many voters and employers, together with prescription medicines
The corporations deliberate a Monday morning convention name to debate the deal.
The deal’s impression on prescription drug costs is unsure. Aetna clients could first see some modifications in how their plans are managed.
Over time, a bulked-up CVS might achieve extra negotiating leverage over costs, however it’s troublesome to say how a lot would trickle right down to clients.
The deal could generate a new stream of consumers to CVS shops, lots of which now supply a rising menu of medical providers in addition to the traditional fare of prescriptions and chilly-and-cough provides.
That could assist gasoline a push by CVS to turn into extra of a one-cease store for health care, a place the place sufferers can get blood drawn, then see a nurse practitioner and decide up prescriptions.
CVS will purchase insurance coverage big Aetna in a roughly $69 billion deal that will assist the drugstore chain present extra health care and maintain a key shopper
By buying Aetna, CVS can enter new companies together with health financial savings accounts, residence care and telemedicine and go after extra of the shopper’s health-care dollars, stated RBC analyst George Hill.
With conventional strains blurring in health care, CVS should fear about competitors from the likes of UnitedHealth Group Inc. The nation’s largest health insurer additionally manages a giant pharmacy advantages enterprise, and it runs physician practices and clinics.
CVS and Aetna collectively ‘have the probability to shut the aggressive hole shortly,’ Hill stated. ‘You can see the path the place CVS goes.’
CVS Health began including clinics to its drugstores years in the past and has been increasing the providers they provide. Customers can get physicals, flu photographs or remedies for sinus infections at the clinics. They can also obtain ldl cholesterol screenings or discover assist monitoring continual circumstances reminiscent of diabetes.
Talks between the two have been reported since late October, and are believed to have been pushed by rumors of on-line purchasing behemoth Amazon’s entry into the drugstore market
Analysts say clinics aren’t particularly worthwhile, however they’re essential as a result of they draw individuals into the shops and assist construct deeper buyer relationships.
The clinics additionally present providers that cannot be bought on-line. Like different retailers, drugstores are struggling to carry onto clients who’re shopping for extra items via retailers comparable to Amazon.
By increasing its medical providers, CVS would primarily be ‘changing aisles and merchandise with providers,’ Jefferies analyst Brian Tanquilut stated. He and others on Wall Street anticipate the Aetna deal to gasoline a health care providers enlargement for CVS. The firm may open extra clinics or add providers reminiscent of eye care or listening to assist facilities.
The deal additionally will assist CVS hold Aetna’s enterprise managing the insurer’s pharmacy advantages. That could maintain tens of millions of consumers away from Amazon if the retail big decides to broaden into prescribed drugs. Investors have been frightened about that prospect since reviews about the risk first appeared earlier this yr. Amazon has not commented.
Aetna stockholders will get $145 money and zero.8378 CVS shares for every Aetna share. They would personal 22 % of the firm, with 78 % remaining with present CVS shareholders.
Antitrust regulators nonetheless have to approve the deal, and that is just not assured.
Last month, the Justice Department sued to dam AT&T’s $85 billion buy of Time Warner. Regulators additionally sued to cease Aetna’s proposed $34 billion buy of Humana Inc. – a deal that fell aside earlier this yr. Opposition from antitrust regulators additionally helped kill Anthem Inc.’s $48 billion bid to purchase Cigna Corp.
The latter two have been offers in which one main health insurer sought to purchase one other.
‘This is a totally different sort of alignment,’ Carl Tobias, a regulation professor at the University of Richmond, stated of the CVS transfer. ‘If it really works nicely for shoppers, then perhaps it is going to be OK (to regulators). The corporations could make that pitch.’
Leerink analyst David Larsen stated in a current word that the CVS-Aetna deal has a respectable probability of approval as a result of regulators might consider it can put strain on producers to carry down drug costs.
Hartford, Connecticut-based Aetna and Woonsocket, Rhode Island-based CVS each handle Medicare prescription drug protection. Some of that enterprise might should be bought to deal with antitrust considerations.